QbD Group
    Regulatory Update

    Expanded eIFU Eligibility under EU Regulation 2025/1234

    Learn how Commission Implementing Regulation (EU) 2025/1234 broadens electronic Instructions for Use (eIFUs) for professional medical devices, the compliance steps required, and how IFUcare can help.

    2025年7月3日3 分钟阅读

    Expanded rules for electronic instructions for use (eIFUs)

    Effective: Published June 27th, entering into force 20 days later

    Amends: Commission Implementing Regulation (EU) 2025/1234

    Purpose: To broaden the scope of devices eligible to provide IFUs in electronic form instead of paper.

    What changed?

    The EU now allows all medical devices and their accessories intended for professional users to provide electronic Instructions for Use (eIFUs). This means the scope is no longer limited to devices like (active) implantables, fixed installed medical devices, and devices with a built-in system for visually displaying instructions. This change responds to industry demand and digital transformation trends.

    Below you’ll find the key highlights of the regulation, or you can consult the document of the Official Journal of the European Union.

    Key highlights

    1\. Wider scope of eligibility

    • All devices and their accessories intended for professional use are now eligible
    • Applies even to devices without an intended medical purpose listed in Annex XVI to Regulation (EU) 2017/745
    • Devices under transitional MDR provisions are included
    • If lay persons are likely users, a paper IFU is still required for them

    2\. Compliance requirements remain strict

    • A documented risk assessment is still mandatory
    • Manufacturers must ensure:
      • Secure and user-friendly access to eIFUs
      • Backup and emergency protocols
      • Website uptime and data protection (GDPR)
        • Paper IFUs must be available on request, within 7 days

    3\. Labeling and website requirements

    • Product labels must indicate eIFUs are provided
    • Website must host current IFU and historical versions must be at least made available on request
    • eIFUs must be accessible in official EU languages, as applicable
    • From the moment registration in EUDAMED becomes mandatory, internet access URLs must be registered

    How you can take advantage of the updated regulation

    You can now:

    • Replace printed IFUs for a much wider range of devices
    • Digitize documentation workflows, reducing costs
    • Improve update speed and support sustainability goals. But you must still meet strict EU MDR/IVDR requirements regarding the IFU for content, delivery, labeling, and traceability.

    Your partner in eIFU compliance

    Commission Implementing Regulation (EU) 2025/1234 opens the door much wider for manufacturers to adopt electronic IFUs but it also reinforces the need for controlled access, version tracking, and alignment with EUDAMED.

    IFUcare can support full eIFU compliance. Our platform offers:

    • Commonly used formats: we provide eIFUs in widely accepted formats that can be read with freely available software.
    • Security: robust protection against hardware and software intrusions to safeguard your information.
    • Minimal downtime: our platform is designed to reduce server downtime and display errors, ensuring that your eIFUs are always available.
    • Multilingual support: clear indication of the languages in which the eIFUs are provided.
    • Stable internet address: guaranteed stable and accessible internet address for your eIFUs, in compliance with regulatory requirements.
    • Version control: access to all previous versions of your eIFUs and their publication dates.

    关于作者

    QbD Group
    QbD Group

    QbD Group is a global life sciences consultancy supporting companies from idea to patient. With over 700 experts, QbD delivers regulatory, quality, and compliance services across pharma, biotech, medical devices, and diagnostics.

    Regulatory Affairs services

    Navigate Regulatory Complexity with Confidence

    Navigate complex regulatory landscapes with expert guidance across pharmaceuticals, medical devices, and IVD.

    Read more
    分享本文

    订阅生命科学领域的最新动态

    专家观点直达您的收件箱——选择您的兴趣。

    绝无垃圾邮件。随时取消订阅。

    继续阅读

    相关内容

    我们使用 Cookie 来改善您的体验

    我们使用必要的 Cookie 来保证网站功能,以及可选的分析 Cookie 来改善我们的服务。 阅读我们的 隐私政策Cookie 政策.